ClinicalTrials.gg
Drug

Vandetanib clinical trials

Also written Zactima, ZD6474, Caprelsa and SAR390530.

studies test it
98
open now
0
in phase 3
6
first study started
2002

How each study uses vandetanib is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
6 Apr 2011 · CAPRELSA · NDA 022405 (FDA, Drugs@FDA)
European Union
16 Feb 2012 · Caprelsa · EMEA/H/C/002315 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Vandetanib
57
ZD6474 (vandetanib)
9
ZD6474 (vandetanib) 100mg
3
ZD6474 (vandetanib) 300mg
3
Caprelsa (vandetanib)
2

Brand

Zactima
39
Caprelsa
10

Development codes

ZD6474
37
SAR390530
6
AZ6474
1

Studies by the year they started

98 studies that test it; most in 2008 (20)

Studies that test vandetanib, by start year
YearStudies
20023
20032
20043
20054
200616
200719
200820
20098
20102
20111
20129
20134
20143
20153
20181

By phase

A phase 1/2 study counts in both.

Phase 1
41
Phase 2
53
Phase 3
6
Phase 4
1
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 43 · Other 55

Genzyme, a Sanofi Company (35) · Sanofi (8) · National Cancer Institute (NCI) (8) · M.D. Anderson Cancer Center (6) · Dana-Farber Cancer Institute (4) · Samsung Medical Center (2) · SWOG Cancer Research Network (2) · St. Jude Children's Research Hospital (2)

Often tested with

Tested in the same studies.

Carboplatin (4) · Everolimus (3) · Gemcitabine (3) · Oxaliplatin (3) · Imatinib (3) · Fluorouracil (2) · Paclitaxel (2) · Docetaxel (2)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 1 phase 3 study under way

Vandetanib is the comparator. A study of two new drugs counts under both.

Studies

Open first, then newest update. How each study uses vandetanib is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 98

See all 98 studies that test vandetanib →

Given beside what is tested · 5 — vandetanib is usual care or a partner of the new treatment
As the comparator · 2 — what is tested is compared with vandetanib

Codes

What other systems call vandetanib · ClinicalTrials.gg INT004437

  • MeSH (NLM) C452423vandetanibConfirmed NLM, Wikidata
  • UNII (FDA) YO460OQ37KVANDETANIBConfirmed FDA, NLM, Wikidata
  • RxNorm 1098413Confirmed FDA, Wikidata
  • Wikidata Q7914515vandetanibConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C2737VandetanibOne source FDA
  • DrugBank DB05294One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.